About Jindal Texofab Limited
Data last updated: 05 January 2026
Jindal Texofab Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in textile and fabric production, a part of the broader manufacturing sector. Incorporated on 27 February 1991, the company has been in operation for over 35 years.
Registered with ROC Mumbai under CIN U17100MH1991PLC060530.
Capital: an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹1.8 Cr. Formerly known as Karnavati Synthetics Limited. It is led by directors including Mayank Khetan and Madhulika Jitendra Agrawal.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Pushpawati Bldg. No.2 2Nd Floor Chandanwadi, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2024, the company reported a revenue of ₹67.02 Cr, a growth of 1% compared to the previous year.
The company has a workforce of approximately 3 employees as per the latest available data.
The company is associated with 2 brands - Jindal Home, Jindal Worldwide Ltd.. As per MCA filings, the company has open charges of ₹17.94 Cr and satisfied charges of ₹92.81 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jindalhome.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPushpawati Bldg. No.2 2Nd Floor Chandanwadi, Mumbai, Maharashtra, India – 400002
-
IndustryManufacturing, Textile & Fabric Production
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Jindal Texofab Limited
Jindal Texofab Limited operates two associated brands: Jindal Home and Jindal Worldwide Ltd.. These brands represent Jindal Texofab Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Jindal Home is a brand offering high-quality bed sheets, comforters, towels, and bedspreads for home use. | jindalhome.com | |
| Textile products including denim and yarn are manufactured and exported. | jindaltextiles.com |
Competitors & Alternatives of Jindal Texofab Limited
Brands and companies operating in the same space as Jindal Texofab Limited include Indo Count, Sportking, Jaykay Enterprises and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Home textile products including bed sheets and bedding are manufactured. | Mumbai, India, India | 1988 |
|
|
Yarns, fabrics, and garments are manufactured and retailed by Sportking. | Ludhiana, India, India | 1989 |
|
|
Yarn and cotton are manufactured by Jaykay Enterprises in India. | Kanpur, India, India | 1991 |
|
|
Textiles and related products are manufactured in India. | Mumbai, India, India | 1986 |
|
|
Yarns and threads are contract-manufactured for textile and apparel industries. | Delhi, India, India | 1979 |
|
|
Denim fabrics are contract-manufactured in Bhilwara, India. | Bhilwara, India, India | 2009 |
|
|
Fabrics are manufactured on a contract basis by A.K. Spintex. | Bhilwara, India, India | 1994 |
|
|
Linens, towels, and home furnishings are manufactured and distributed. | Mumbai, India, India | 1879 |
|
|
Wholesale textiles are purchased via an online platform. | Jaipur, India, India | 1996 |
|
|
Home textiles such as towels, bedding, and fabrics are manufactured. | Weifang, China, China | 1987 |
Business Activity of Jindal Texofab Limited
Jindal Texofab Limited is engaged in the principal business activity of manufacturing, with detailed activities including textile, leather and other apparel products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C2 | Textile, leather and other apparel products | ********* |
Auditor Details of Jindal Texofab Limited
Jindal Texofab Limited is audited by RAVI PRABODHKUMAR SHAH for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAVI PRABODHKUMAR SHAH | blur-value | blur-value | blur-value |
Board of Directors of Jindal Texofab Limited
Jindal Texofab Limited is currently managed by 3 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Mayank Khetan
Also directs:
Uma Weavers Private Limited
|
Director | 01 Sep 2015 | 10 Years 10 Months | Current |
|
Madhulika Jitendra Agrawal
Also directs:
Claremont Home Textiles Private Limited, Corey Developers Llp
|
Director | 18 Dec 2019 | 6 Years 6 Months | Current |
|
Yash Jitendra Agrawal
Also directs:
Ritu Orchards Pvt Ltd, Madhulika Estate Enterprise Private Limited, Jindal Gsl Private Limited and 3 more
|
Director | 24 Aug 2017 | 8 Years 10 Months | Current |
Financials of Jindal Texofab Limited FY 2024 filings available
Jindal Texofab Limited reported revenue of ₹67.02 Cr (up 1% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Jindal Texofab Limited
As of FY 2024, Jindal Texofab Limited's shareholding pattern shows 99.96% by promoters, 0.04% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Jindal Texofab Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2024 | Others | ₹15 Cr | Open |
| 12 Jun 2023 | Others | ₹94 Lakh | Open |
| 19 Jul 2013 | Indian Bank | ₹1 Cr | Open |
| 14 Jun 2013 | Indian Bank | ₹1 Cr | Open |
| 12 Jun 2023 | Others | ₹16 Cr | Satisfied |
Total charge records: 12 View all charges
Employees and EPFO Compliance at Jindal Texofab Limited
Jindal Texofab Limited has a workforce of 3 employees as of Feb 12, 2025.
Employee Count & EPFO Data of Jindal Texofab Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Jindal Texofab Limited
GSTIN & GST Filing Data of Jindal Texofab Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Jindal Texofab Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Jindal Texofab Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Jindal Texofab Limited
MSME Payment Delays by Jindal Texofab Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Jindal Texofab Limited
Subsidiaries & Group Companies of Jindal Texofab Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Jindal Texofab Limited with ownership details.
MCA Filings & Documents of Jindal Texofab Limited
MCA Filings & Documents of Jindal Texofab Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Jindal Texofab Limited
Frequently Asked Questions about Jindal Texofab Limited
Jindal Texofab Limited is an active public limited company in the manufacturing sector based in Mumbai, Maharashtra, India. It was incorporated on 27 February 1991 (35+ years old) and is registered under CIN U17100MH1991PLC060530. The company has 3 employees.
Jindal Texofab Limited reported revenue of ₹67.02 Cr for FY 2024 (up 1.00% YoY).
The current directors of Jindal Texofab Limited are:
The primary industry of Jindal Texofab Limited is manufacturing. The company specifically operates in textile and fabric production. The company is currently active in this sector.
Jindal Texofab Limited can be reached at the registered office: Pushpawati Bldg. No.2 2Nd Floor Chandanwadi, Mumbai, Maharashtra, India – 400002, or through the website jindalhome.in.
The authorised capital is ₹3.5 Cr, and the paid-up capital is ₹1.8 Cr.